Insulet Corporation is a publicly traded company, which means it is owned by its collective shareholder base rather than any single private individual or parent organization. Its ownership is highly diverse, including major global institutional investment firms, pension funds, mutual fund managers, and thousands of individual retail investors who purchase shares on the Nasdaq stock exchange. No single entity owns a controlling interest in Insulet; instead, the company is managed by its Board of Directors and executive team, who are legally bound by fiduciary duties to act in the best interests of these shareholders. While early venture capital firms and the original founders may have held significant stakes during the company's developmental stages, the equity landscape is now defined by the broad participation of the public market, which dictates the company's valuation and provides the capital necessary for its continued growth and technological innovation.